The experimental blood test is called PANXEON. It detected about 87% of stage one and stage two pancreatic cancers. That is good news because these are earlier stages.
Earlier instead of too late: In an international study, a new blood test detected 86.8% of pancreatic carcinomas in stage I or II. PANXEON combines a signature of ten microRNAs with the tumor marker CA19-9, provided few false alarms in people at low risk and also recognized a part of dangerous cancer precursors. Los Angeles (U.S.A.). Pancreatic cancer remains long [...] The article Blood test detects pancreatic cancer already in early stages app…